We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
-0.42%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$388M
AUM Growth
-$58.9M
Cap. Flow
-$52M
Cap. Flow %
-13.41%
Top 10 Hldgs %
66.6%
Holding
38
New
1
Increased
13
Reduced
15
Closed
7

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$10.2M
2
ELV icon
Elevance Health
ELV
+$5.61M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$5.53M
4
BIIB icon
Biogen
BIIB
+$3.77M
5
ZBH icon
Zimmer Biomet
ZBH
+$3.33M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$14.4M
2
CVS icon
CVS Health
CVS
+$12.3M
3
OGN icon
Organon & Co
OGN
+$12M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$9.43M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$6.85M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
1
Gilead Sciences
GILD
$167B
$54.5M 14.04%
883,106
+39,679
+5% +$2.5M
BIIB icon
2
Biogen
BIIB
$30.4B
$29.4M 7.58%
110,230
+17,733
+19% +$3.77M
INCY icon
3
Incyte
INCY
$23.4B
$27.9M 7.19%
418,794
-40,635
-9% -$3M
BMY icon
4
Bristol-Myers Squibb
BMY
$124B
$25.1M 6.48%
353,627
+41,931
+13% +$3.04M
CAH icon
5
Cardinal Health
CAH
$53.5B
$23.9M 6.16%
358,700
-27,288
-7% -$1.73M
MRK icon
6
Merck
MRK
$315B
$21.8M 5.62%
253,159
-161,179
-39% -$14.4M
MDT icon
7
Medtronic
MDT
$106B
$21.8M 5.62%
269,957
-20,564
-7% -$1.85M
ELV icon
8
Elevance Health
ELV
$80.9B
$20.9M 5.39%
46,032
+11,732
+34% +$5.61M
ZBH icon
9
Zimmer Biomet
ZBH
$17.6B
$17.4M 4.48%
166,080
+30,331
+22% +$3.33M
CNC icon
10
Centene
CNC
$32.8B
$15.7M 4.04%
201,555
+19,756
+11% +$1.77M
BSX icon
11
Boston Scientific
BSX
$65.4B
$15M 3.86%
387,184
-145,551
-27% -$5.84M
CI icon
12
Cigna
CI
$74.5B
$14M 3.61%
50,517
-15,766
-24% -$4.44M
BRKR icon
13
Bruker
BRKR
$8.86B
$12.6M 3.25%
237,958
-13,084
-5% -$782K
SGEN
14
DELISTED
Seagen Inc. Common Stock
SGEN
$11.6M 2.99%
84,730
+33,935
+67% +$5.53M
NUVA
15
DELISTED
NuVasive, Inc.
NUVA
$10.9M 2.81%
248,649
+1,147
+0.5% +$55.6K
BMRN icon
16
BioMarin Pharmaceuticals
BMRN
$11.5B
$9.29M 2.39%
109,604
+4,345
+4% +$387K
BAX icon
17
Baxter International
BAX
$11.7B
$9.1M 2.35%
+169,028
New +$10.2M
QGEN icon
18
Qiagen
QGEN
$8.49B
$8.42M 2.17%
192,453
+2,211
+1% +$109K
IONS icon
19
Ionis Pharmaceuticals
IONS
$8.99B
$7.26M 1.87%
164,223
-1,216
-0.7% -$51.2K
BIO icon
20
Bio-Rad Laboratories Class A
BIO
$8.15B
$5M 1.29%
11,988
+203
+2% +$101K
SAGE
21
DELISTED
Sage Therapeutics
SAGE
$4.53M 1.17%
115,696
-2,780
-2% -$107K
PTCT icon
22
PTC Therapeutics
PTCT
$6.52B
$4.35M 1.12%
86,692
+1,828
+2% +$89.6K
CVS icon
23
CVS Health
CVS
$137B
$4.14M 1.07%
43,443
-124,668
-74% -$12.3M
ITCI
24
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$3.19M 0.82%
68,612
-12,231
-15% -$639K
UHS icon
25
Universal Health Services
UHS
$9.15B
$2.39M 0.62%
27,077
– –
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q3 2022 Portfolio in Review

As of Q3 2022, Sector Gamma AS held 38 positions worth $388M, down 13% from $447M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Sector Gamma AS withdrew a net $52M in Q3 2022, closing 7 positions and reducing 15 holdings. Its most notable exit was Organon & Co, an estimated $12M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in Baxter International worth $9.1M.

  • Sector Gamma AS's largest Q3 2022 buy was Baxter International: 169,028 shares worth $9.1M.
  • Sector Gamma AS added most to Elevance Health in Q3 2022, an estimated $5.61M increase.
  • Sector Gamma AS's biggest Q3 2022 reduction was Merck, cutting an estimated $14.4M.
  • Sector Gamma AS fully exited Organon & Co in Q3 2022, selling an estimated $12M.
  • Sector Gamma AS's ten largest holdings make up 67% of its $388M portfolio in Q3 2022.
  • Sector Gamma AS opened 1 new position and closed 7 in Q3 2022.
  • Sector Gamma AS's portfolio value fell 13% quarter-over-quarter to $388M.

Based on Sector Gamma AS's 13F filing for Q3 2022, filed 9 Nov 2022.